THE COLLABORATION WILL FOCUS ON INTEGRATING DNA STORAGE AS A NEW, ULTRA- SECURE COLD ARCHIVE TIER WITHIN SCALITY-MANAGED STORAGE ENVIRONMENTS.
I N T E L L I G E N T T E C H N O L O G Y STORAGE
Scality and Biomemory to pioneer ultra-secure, DNA-based data archives
Scality, a global leader in data infrastructure software for AI-era storage at scale, has announced a strategic partnership with Biomemory, a pioneer in industrialgrade DNA-based data storage systems, to accelerate the development and enterprise integration of DNA-based cold archive storage.
Together, the two companies will work to position DNA storage as a viable, ultra-secure and long-term archival tier within modern object storage environments, complementing existing flash, disk and tape infrastructure rather than replacing it. To strengthen the partnership, Scality CEO, Jerome Lecat, is on Biomemory ' s board of directors.
The partnership brings together Scality ' s software-defined S3 object storage platform, built to span and optimise across multiple storage media types, with Biomemory ' s data centre-oriented DNA storage systems, which are designed with enterprise-grade metrics and a modular architecture. The collaboration will focus on integrating DNA storage as a new, ultra-secure cold archive tier within Scality-managed storage environments including Scality ADI, its autonomous data infrastructure solution. The integration roadmap will be developed jointly by both companies in the coming months.
DNA data storage is transitioning from scientific research to commercial application, establishing itself as an archival storage solution optimised for extreme longevity and minimal operational demands. This emerging tier is uniquely suited for data that must endure for decades, offering near-zero media refresh requirements and zero power consumption at rest. demands of the data it holds. DNA storage represents the logical culmination of that spectrum: a cold archive tier with density, secure immutability and longevity that no conventional medium can approach. Our partnership with Biomemory is a strategic investment in owning that future. By bringing DNA into the Scality ecosystem now, we ensure our customers, which include the world ' s most demanding enterprises, governments and service providers, will be ready to harness it as it matures. And by being on Biomemory ' s board, I ' m personally committed to helping accelerate that journey for the entire industry," said Jerome Lecat, CEO, Scality. �
“
THE COLLABORATION WILL FOCUS ON INTEGRATING DNA STORAGE AS A NEW, ULTRA- SECURE COLD ARCHIVE TIER WITHIN SCALITY-MANAGED STORAGE ENVIRONMENTS.
Its core value proposition is ideal for‘ keep forever, read rarely’ scenarios where data integrity and extreme longevity are nonnegotiable. Key applications include national archives, scientific and genomic data repositories, media and entertainment preservation, regulated financial and healthcare records and sovereign or defence workloads. The most immediate demand is expected from organisations responsible for preserving highvalue data over multi-decade timeframes, where loss, corruption or unreadability could carry severe financial, legal, operational or societal consequences.
The recent acquisition of assets from DNA pioneer, Catalog Technologies, strengthens Biomemory ' s foundation and accelerates its market readiness. This strategic move marks a decisive step in Biomemory ' s journey to bring DNA Data Storage from the lab to an industrialised IT solution.
" The future of data storage is not a single medium; it is a spectrum of storage qualities, each optimised for the
www. intelligentdatacentres. com 31